We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiopharma Cred. Share News (BPCR)

Share Price Information for Biopharma Cred. (BPCR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.876
Bid: 0.876
Ask: 0.878
Change: -0.002 (-0.23%)
Spread: 0.002 (0.228%)
Open: 0.876
High: 0.88
Low: 0.874
Prev. Close: 0.878
BPCR Live PriceLast checked at -
BioPharma Credit is an Investment Trust

To generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: BioPharma Credit Net Asset Value Dips; Portfolio "Resilient"

Wed, 16th Sep 2020 17:51

BioPharma Credit PLC - Exeter-based life sciences debt investment trust - Net asset value per share USD1.0033 as at June 30, down 1.8% from USD1.0217 December 31. "During the period, the Covid-19 pandemic led to restrictions to the movement of people and disruption to business operations. Thus far the portfolio has proved resilient." Due to "extremely volatile equity market conditions", discount to NAV of shares exceeds 5%, triggering discount control resulting in repuchase of 59,694 shares after H1 close. Share price has since recovered. BioPharma Credit pays dividends totalling USD0.0478 per share in the period, up from USD0.0368 per share in the first half of 2019.

Pedro Gonzalez de Cosio, chief executive of BioPharma Credit's investment manager: "The environment continues to be attractive for the Company's investment strategy given the considerable and growing capital needs of the sector. This will be potentially enhanced by an anticipated increase in sector M&A activity and a slowdown in equity issuance that has tended historically to lead to a greater appetite for fixed income as a source of capital for the life sciences industry."

Current stock price: USD1.02

Year-to-date change: down 0.5%

By Anna Farley; annafarley@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
19 Oct 2018 11:26

BioPharma Credit To Raise USD150 Million Via Placing (ALLISS)

LONDON (Alliance News) - BioPharma Credit PLC said Friday it intends to raise USD150 million via share placing.The company will issue 146.3 million shares at USD1.025 per share, a 2.9% to a

Read more
27 Sep 2018 12:43

BioPharma Credit Interim Net Asset Value Flat, Income Rises Sharply

LONDON (Alliance News) - BioPhamra Credit PLC on Thursday reported a sharp rise in income in the first halfIn the six months ended June, the life sciences debt investment trust increased to

Read more
20 Sep 2018 13:31

BioPharma Credit Loans USD150 Million To Amicus Therapeutics

LONDON (Alliance News) - BioPharma Credit PLC said Thursday that it has loaned USD150 million to Amicus Therapeutics Inc, a rare metabolic disease-focused biopharmaceutical company.Under in

Read more
2 Jul 2018 12:55

BioPharma Funds USD200 Million TESARO Loan Alongside Other Investors

LONDON (Alliance News) - BioPharma Credit PLC said Monday it has funded, alongside other investors, the USD200 million second tranche of a USD500 million loan to TESARO Inc.The company and

Read more
4 May 2018 12:26

Pablo Legorreta Doubles BioPharma Credit Stake To 7.1% (ALLISS)

LONDON (Alliance News) - BioPharma Credit PLC said Friday Pablo Legorreta doubled his stake in the pharmaceutical debt investor in a transaction on Monday.Legorreta - the founder and chief

Read more
2 May 2018 16:51

Pharmaceutical Investors Cuts BioPharma Credit Stake Below 3% (ALLISS)

LONDON (Alliance News) - Life-science focused debt investor BioPharma Credit PLC said on Wednesday Pharmaceutical Investors LP sold shares in the company on Tuesday.After the transaction a

Read more
1 May 2018 16:26

BioPharma Invests USD194 Million In US Pharma Firm Sebela

LONDON (Alliance News) - BioPharma Credit PLC said Tuesday that it has invested USD194 million in a unit of US-based Sebela Pharmaceuticals Inc.The life science-focused debt investor has a

Read more
23 Apr 2018 13:06

BioPharma Credit To Invest USD191 Million In Pharmaceutical Developer

LONDON (Alliance News) - Life science-focused debt investor BioPharma Credit PLC said on Monday it has become the lead investor and collateral agent for a USD315.0 million loan to an unnamed will

Read more
8 Mar 2018 12:21

BioPharma Credit To Raise USD300 Million As Net Asset Value Rises (ALLISS)

LONDON (Alliance News) - Life sciences debt investor BioPharma Credit PLC said Thursday it has had a "highly successful" 2017 and announced a share issue to raise on

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.